GlassScriptPhysician profile
John R Harding
NPI 1043275019
$3,085.09
in general payments reported to CMS, 2019-2025
36 companies · $74.50 in 2025
The $74.50 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,324 · 2020: $197 · 2021: $109 · 2022: $132 · 2023: $716 · 2024: $532 · 2025: $74.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $507.00 | 2019 | |
| Abbvie INC. | $258.57 | 2022-2025 | |
| Janssen Biotech, INC. | $214.71 | 2019-2023 | Erleada |
| Astellas Pharma US INC | $190.22 | 2019-2024 | Xtandi |
| Myriad Genetic Laboratories, INC. | $187.65 | 2022-2024 | Prolaris, Myrisk |
| Merck Sharp & Dohme LLC | $153.57 | 2022-2024 | Keytruda, Welireg |
| Neotract INC. | $138.41 | 2019 | |
| Teleflex LLC | $136.50 | 2023 | Urolift |
| Clarus Therapeutics INC. | $133.67 | 2020-2021 | |
| Pfizer INC. | $118.45 | 2019-2024 | |
| Boston Scientific Corporation | $97.31 | 2024-2025 | Ams 700, Spaceoar Vue System - 10ml |
| Laborie Medical Technologies Corp. | $89.58 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Sumitomo Pharma America, INC. | $78.21 | 2023 | Gemtesa |
| Antares Pharma, INC. | $74.75 | 2021-2024 | Xyosted, Nocdurna, Tlando |
| Halozyme INC | $71.58 | 2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $71.09 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.80 | 2019-2023 | |
| 180 Medical, INC. | $58.84 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $53.81 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $44.84 | 2019-2020 | |
| Amgen INC. | $38.17 | 2019 | |
| Blue Earth Diagnostics | $36.89 | 2019 | |
| Ambu INC. | $35.99 | 2023 | |
| Rochester Medical Corporation | $27.05 | 2019 | |
| Olympus America INC. | $22.17 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $21.57 | 2021 | |
| Tolmar, INC. | $21.25 | 2023 | |
| Convatec INC. | $19.75 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.58 | 2023 | Opdivo |
| Tolmar Pharmaceuticals, INC. | $17.91 | 2020 | |
| Tempus Ai, INC | $17.33 | 2024 | |
| Coloplast Corp | $15.49 | 2023 | Speedicath |
| Axonics, INC. | $14.87 | 2024 | Axonics, Bulkamid |
| Zyla Life Sciences, INC. | $14.41 | 2019 | |
| Cook Medical LLC | $12.56 | 2021 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Harding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.